Product Theaters

Product Theater sessions focus on particular products or a single facet of diabetes. Product Theater sessions do not provide continuing education credit. Breakfast will be served to the first 150 attendees. Lunch will be served at the noon sessions to the first 300 attendees. An afternoon break will be offered to the first 300 attendees at the later sessions. A light dinner will be served to the first 300 attendees in the evening.

Several states have enacted state regulations prohibiting sponsoring companies from providing any food, beverages and/or meals to healthcare professionals practicing in those states. Please consult your state regulations and ethics laws to see if such prohibition would apply to you.

In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at this educational program is limited to healthcare professionals. Accordingly, attendance by guests or spouses is not appropriate and cannot be accommodated.

NEW! Seating is first come, first serve. Doors will open 15 minutes before scheduled start.

Thursday, August 3

5:30 pm – 6:15 pm
PT02
Therapeutic Dosing with Dexcom G5 CGM: The New Standard of Care for Intensive Insulin-Requiring Patients

Room 135-139
Supported by Dexcom




Highly interactive, didactic presentations from world renown diabetes healthcare professionals and leaders in the field of advanced, real-time continuous glucose monitoring and therapeutic dosing. You will additionally experience hands-on demonstrations of the Dexcom G5® CGM System as well as have the opportunity to actively participate in question and answer sessions with the faculty Presenters and the Dexcom Team.

Davida F. Kruger MSN, APN-BC, BC-ADM, Henry Ford Health System, New Center One, Certified Nurse Practitioner Henry Ford Health System Division of Endocrinology, Diabetes, Bone and Mineral Disease

Keri J. Leone MS, RD, CDE, Senior Director, Global Professional Education, Dexcom, Inc.

Friday, August 4

6:30 am – 7:15 am
PT03
MiniMed™670G System With SmartGuard™ HCL Technology: Driving Patient Outcomes Through Automation

Room 135-139
Supported by Medtronic and Ascensia Diabetes Care





Come learn about the MiniMed 670G system–the world’s first FDA-approved Hybrid Closed Loop System for the management of type 1 diabetes. The presenters will share clinical evidence from the pivotal trial as well as realworld experience, best practices and patient case studies.
 
Jennifer Sherr, MD, PHD, Pediatric Endocrinologist, Associate Professor Yale School of Medicine
 
Trish Comrie-Scheer, RD, CDE, Regional Clinical Manager, Medtronic

12:15 pm – 1:00 pm
PT04
Insulin Monotherapy for Patients with Type 2 Diabetes and Uncontrolled Blood Glucose on High Doses of Insulin

Exhibit Hall – Product Theater A
Supported by Lilly USA, LLC




The program is about a concentrated human insulin indicated to improve glycemic control for specific patients. Identify patients who may benefit from treatment, debunk myths pertaining to critical efficacy and safety information, and learn how to integrate the use of the product into your practice with effective dosing algorithms.

Lowell R. Schmeltz, MD, FACE, Associate Professor, Oakland University William Beaumont School of Medicine Royal Oak, Chief, Division of Endocrinology and Metabolism, Medical Center Huron Valley-Sinai Hospital Commerce

12:30 pm – 1:15 pm
PT05
A Patient-Centered Approach to Help Awaken a Transformation for Adults With T2DM

Exhibit Hall – Product Theater B
Supported by Janssen Pharmaceuticals, Inc.




This program will provide an overview of the sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of patients with type 2 diabetes.Topics include the pathophysiology of type 2 diabetes and associated cardiometabolic risk factors, how SGLT2 inhibitors work, results from active-controlled and real-world evidence studies supporting the use of SGLT2 inhibitors vs other agents, and important safety information, followed by a question-and-answer session. This promotional educational activity is sponsored by Janssen Pharmaceuticals, Inc. It is not certified for continuing medical education.

Eden Miller, DO, Diabetes Nation

Curtis Triplitt, PharmD, CDE, BCPS, Clinical Associate Professor, Medicine/ Diabetes UTHSCSA, Texas Diabetes Institute

Saturday, August 5

6:30 am – 7:15 am
PT06
The Next Generation Omnipod Systems

Exhibit Hall – Product Theater A
Supported by Insulet




Learn about the future of innovation including Omnipod Dash platform. There will be an exclusive update on the clinical progress of Omnipod Horizon Automated Glucose Control System.
 
Irang Ly, MBBS, FRACP, PhD, Vice President and Medical Director, Insulet Corporation
 
Jason O’Connor, Director of Advanced Technologies, Insulet Corporation

11:45 am – 12:30 pm
PT07
It’s Time to Rethink Professional CGM: the New FreeStyle Libre Pro System

Exhibit Hall – Product Theater A
Supported by Abbott Diabetes Care




Welcome to a new era of simplicity and convenience in Professional Continuous Glucose Monitoring. Introducing the new FreeStyle Libre Pro System — an innovative glucose assessment tool that provides a complete glycemic profile to help healthcare professionals make more informed treatment decisions.
 
Etie Moghissi MD, FACP, FACE, Associate Clinical Professor of Medicine, UCLA David Geffen School of Medicine, Marina Diabetes and Endocrinology Center

12:00 pm – 12:45 pm
PT08
Introducing the CONTOUR®NEXT ONE Meter and CONTOUR™DIABETES App: Providing Remarkable Accuracy and Smart Diabetes Management

Exhibit Hall – Product Theater B
Supported by Ascensia




Self-monitoring of blood glucose is an important tool utilized by patients with diabetes and their healthcare providers to assess the effectiveness and safety of their diabetes management plan on glycemic control. The accuracy of patients’ blood glucose monitoring systems (BGMS) plays a key role in detecting and properly managing hypoglycemia, titrating medication doses, adjusting diet and activity, and improving overall decision-making. This product theater presentation will discuss the value of BGMS accuracy, and provide specific information on the proven remarkable accuracy of the CONTOUR® NEXT ONE smart meter and integrated CONTOUR™ DIABETES app, which can help patients to manage their diabetes smarter.

Gary Scheiner, MS, CDE, Owner and Clinical Director, Integrated Diabetes Services

2:45 pm – 3:30 pm
PT09
Simple Solutions for Improving Adherence and Engagement

Exhibit Hall – Product Theater A
Supported by Roche, the makers of Accu-Chek




As healthcare providers feel more pressure to better manage patients with diabetes and the cost for patients to manage their condition rises, simple solutions are essential to promote patient engagement and adherence. Join us to learn how the Accu-Chek Guide system simplifies the testing experience and makes it easy for patients to afford testing, while providing relief to your office through simplified training and eliminating worry about formulary coverage and call backs about prior authorization.
 
Debbie Hinnen, APN, BC-ADM, CDE, FAAN, FAADE, Advanced Practice Nurse and Certified Diabetes Educator, University of Colorado Health- Memorial Hospital Diabetes Center

2:45 pm – 3:30 pm
PT10
Diabetes: Treatment and Management

Exhibit Hall – Product Theater B
Supported by Sanofi




Unpredictable fluctuations in blood glucose levels is one of the many limiting factors in basal insulin use. It is important to consider patients have had their options broadened and it is important for HCPs to know these options.This presentation will examine the pharmacologic, efficacy and safety profiles of a long-acting basal insulin for adult patients.
 
Jodi Strong, DNP, FNPBC, APNP, CDE, BCADM, Clinician and Diabetes Educator, Ministry Medical Group

Sunday, August 6

6:30 am – 7:15 am
PT11
The Role of Inhaled Insulin in the Management of Patients with Diabetes

Exhibit Hall – Product Theater A
Supported by MannKind




This program will introduce practical use of Afrezza® (insulin human) Inhalation Powder in the management of patients with diabetes. Considerations for appropriate patient selection, identification of common adverse events, and proper dosing of Afrezza® will be discussed. Attendees will be provided with the inhalation device and FEV1 demonstrations.

Jerry Meece, RPh, CDE, FACA, FAADE, Director of Clinical Services, Plaza Pharmacy and Wellness Center

12:15 pm – 1:00 pm
PT12
Considerations for Insulin Therapy in Adult Patients with T2DM

Exhibit Hall – Product Theater A
Supported by Sanofi




Explore an approach for adult patients uncontrolled with basal insulin or a GLP-1 receptor agonist that could be used as an adjunct to diet and exercise. This presentation will provide a comprehensive overview of the safety and efficacy of a therapeutic option. It will also cover how to address the multiple pathophysiologic defects that manifest in the disease and may help patients work towards glycemic control.

Jonathan G. Marquess, PharmD, CDE, FAPhA, President, The Institute for Wellness and Education, Inc.

12:30 pm – 1:15 pm
PT13
Pneumococcal Disease in Adults Age Less than 65 years with Diabetes and other Select Chronic Conditions

Exhibit Hall – Product Theater B
Supported by Merck Co., Inc.




Describe Pneumococcal Disease in Adults Age less than 65 years with Diabetes and other select Chronic Conditions. Review CDC Recommendations with Pneumococcal Vaccinations and this population.

© 2016 American Association of Diabetes Educators, All Rights Reserved. Powered By TriStar Publishing, Inc.